Summary
Several postoperative adjuvant therapeutic modalities have been adopted in attempts to reduce the recurrence rate of superficial bladder cancer. However, no definite conclusions on the effectiveness of intravesical chemoprophylaxis have been reached.
A randomized clinical study on intravesical chemoprophylaxis was conducted by the Japanese Urological Cancer Research Group for Adriamycin to compare the recurrence rates among 575 patients with superficial transitional cell carcinoma of the urinary bladder. Group A received 30 mg/30 ml Adriamycin; group B received 20 mg/40 ml Adriamycin; group C received 20 mg/40 ml mitomycin C, and group D, no treatment (for control). Instillation was performed twice a week for 4 weeks after surgery. The postoperative observation period was 18 months. The overall recurrence rate in group D was 61.5%, which was statistically higher than in the other groups. The Adriamycin and Mitomycin C groups showed recurrence rates of 43%–48% and 57%, respectively.
Intravesical Adriamycin and Mitomycin C appeared to be effective in the prophylaxis of recurrence during this observation period. The main side-effect was cystitis syndrome, which was observed in 10%–20% of the patients. There were no life-threatening adverse effects in this series of patients.
Similar content being viewed by others
References
Byar D, Blackard D (1977) Comparison of placebo, pyridoxine, and topical thio-TEPA in preventing recurrence of stage I bladder cancer. Urology 10: 556
Cohen SM (1981) Urinary bladder carcinogenesis with N-substituted aryl compounds: Initiation and promotion. Natl Cancer Inst Monogr 58: 63
Drew JE, Marshall VF (1968) Effect of topical thio-TEPA on the recurrence rate of superficial bladder cancers. J Neurol 99: 740
Esquivel EL, Mackenzie AR, Whitmore WF Jr (1965) Treatment of bladder tumors by instillation of thio-TEPA, actinomycin D, or 5-fluorouracil. Invest Urol 2: 381
Jacobi GH, Thüroft JW (1981) Prophylactic intravesical doxorubicin instillation after TUR of superficial transitional cell tumors: 3 years' experience. In: Bladder cancer. Butterworths, London Boston Sidney Wellington Durban Toronto p 85
Koiso K, Niijima T (1982) Treatment of superficial bladder cancer: a 10-year follow-up study. Jpn J Clin Oncol 12: 165
Koiso K, Fujime M, Ishii Y, Ueno A, Niijima T (1979) Intravesical instillation of adriamycin for the treatment of superficial lesion of bladder cancer. Proceedings of the First Conference on Treatment of Urinary Tract Tumors with Adriamycin. p 19, Vol. I. Kyowa, Tokyo
Koontz WW Jr, Prout GR Jr, Smith W, Frable WJ, Minnis JE (1981) The use of intravesical thio-TEPA in the management of non-invasive carcinoma of the bladder. J Urol 125: 307
Miller AB (1977) The etiology of bladder cancer from the epidemiological viewpoint. Cancer Res 37: 2939
Mishina T, Okada K, Murata S (1975) Mitomycin C bladder instillation therapy for bladder tumors. J Urol 14: 217
Nieh PT, Daly JJ, Heaney JA, Heney NM, Prout GR Jr (1978) The effect of intravesical thio-TEPA on normal and tumor urothelium. J Urol 119: 59
O'Flynn JD, Smith JM, Hanson JS (1975) Transurethral resection for the assessment and treatment of vesical neoplasms. A review of 840 consecutive cases. Eur Urol 1: 38
Prout GR Jr (1982) Heterogeneity of superficial bladder cancer. In: (AUA monograph vol 1) Bladder cancer. Williams & Wilkins, Baltimore, p 149
Pyrah LN, Raper FP, Thomas GM (1964) Report of a follow-up of papillary tumours of the bladder. Br J Urol 36: 14
Saito K, Kubota Y, Takai S (1978) The recurrence after conservative therapy of bladder cancer. Jpn J Urol 69: 373
Schulman CC, Roxencweig M, Staquet M, Kenis Y, Sylvester R (1976) EORTC randomized trial for the adjuvant therapy of T1 bladder carcinoma. Eur Urol 2: 271
Schulman CC, Robinson M, Denis L, Smith P, Viggiano G, de Pauw M, Dalesio O, Sylvester R, EORTC (1982) Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: an EORTC randomized trial comparing thio-TEPA, an epipodophyllotoxin (VM 26) and TUR alone. Eur Urol 8: 207
Soloway MS, Martino C (1976) Prophylaxis of bladder tumor implantation: intravesical and systemic chemotherapy. Urology 7: 29
UICC (1978) Bladder: In: TNM classification of malignant tumours, 3rd edn. UICC, Geneva, p 113
Williams JL, Hammonds JC, Saunders N (1977) Tl bladder tumors. Br J Urol 49:663
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Niijima, T., Koiso, K., Akaza, H. et al. Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer. Cancer Chemother. Pharmacol. 11 (Suppl 1), S79–S82 (1983). https://doi.org/10.1007/BF00256725
Issue Date:
DOI: https://doi.org/10.1007/BF00256725